- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01419912
Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2
August 29, 2011 updated by: Isfahan University of Medical Sciences
Soymilk components such as isoflavones, essential fatty acids, phytoesterols, good fats, inositols might have beneficial effects on controlling complication among diabetic nephropathy patients(DN).Most studies in this regard have been examined the effect of soy consumption on cardiorenal risk factors among patients with DN and there are few data about relationship of soy milk consumption and health effect in patients with DN .
Therefore, we evaluated the effects of soy milk compared to cow's milk on blood pressure, inflammation, oxidative stress and fibrinolytic markers and cardiorenal risk factors among these patients.
This was a cross-over randomized clinical trial which was conducted in Isfahan among diabetic nephropathy patients.
Patients were randomly assigned to consume a diet containing cow's milk or a diet in which only one glass of soy milk was substituted; each one for 4 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Isfahan, Iran, Islamic Republic of
- Isfahan University of Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
28 years to 81 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adults with (>18y old) diagnosis of type 2 diabetics nephropathy (diabetics subjects that had proteinuria more than 300 mg/day and had GFR more than 90 mL/min )
Exclusion Criteria:
- exclusion criteria included diabetic nephropathy patients that they were pregnant or lactation women
- changing dosage of oral hypoglycemic agents
- insulin therapy
- lipid-lowering medications
- use of hormone replacement therapy
- alcohol and cigarette consumption;allergy or intolerance to soybeans or milk
- presence of breast malignant and avoid of advisory diet
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Interventional Model: CROSSOVER
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: soy milk
|
|
EXPERIMENTAL: cow's milk
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
soy milk
|
Secondary Outcome Measures
Outcome Measure |
---|
HbA1c
|
total cholesterol
|
creatinin
|
insulin
|
systolic blood pressure
|
diastolic blood pressure
|
Malondialdehyde
|
fibrinogen
|
Urine creatinine
|
urine protein
|
BUN
|
TNF-α
|
IL6
|
FBS
|
TG
|
hs-CRP
|
d-dimer
|
HDL
|
LDL
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
August 17, 2011
First Submitted That Met QC Criteria
August 17, 2011
First Posted (ESTIMATE)
August 18, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
August 30, 2011
Last Update Submitted That Met QC Criteria
August 29, 2011
Last Verified
January 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- soymilk and nephropathy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Singapore National Eye CentreCompletedIntraocular Inflammation in ChildrenSingapore
Clinical Trials on soy milk
-
University of IdahoFree to Feed Inc.CompletedStress | Microbiome | Food Allergy in InfantsUnited States
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Isfahan University of Medical SciencesCompletedWeight | Waist | Systolic Blood Pressure | Diastolic Blood PressureIran, Islamic Republic of
-
Tulane UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Hypercholesterolemia
-
Tulane UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | HypertensionUnited States
-
University of TorontoDairy Management Inc.RecruitingDietary Proteins | Indicator Amino Acid OxidationCanada
-
Ohio State UniversityCompletedMetabolic Syndrome | Non-alcoholic Fatty LiverUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
University of TennesseeDairy Management Inc.CompletedObesity | OverweightUnited States
-
Taipei Medical UniversityCompleted